Best Traditional Pharmaceuticals Companies in Switzerland
The 31 best Traditional Pharmaceuticals companies in Switzerland in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Galenica.
- HTF Market Intelligence
- Coherent Market Insights
Our analysis of 50 Traditional Pharmaceuticals companies
$3.2b in tracked funding; 51% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2016.
Ranked: Best Traditional Pharmaceuticals companies in Switzerland
| # | Company | Disclosed funding | Last round | Stage | Founder | Founded | Tech stack | Market signals (1y) | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Galenica Manufacturer of pharma and OTC products | $156M | 139 mo ago | Public | Pascal Girardat Founder Lifestage Solutions Ag / Board Member Emeda Ag | 1927 | WordPressApple iCloud MailMicrosoft 365+15 | 9 signals ▼61% Earnings · M&A · Board | — | — |
| 2 | Helsinn Developer of pharmaceutical products focused on cancer and chronic diseases | — | 46 mo ago | Late Stage | Gabriele Braglia Founder | 1976 | WordPressApple iCloud MailMicrosoft 365+18 | 8 signals Leadership | — | — |
| 3 | Vifor Pharma Benelux Provider of plasma-derived and recombinant therapies, and vaccines | — | 116 mo ago | Acquired | — | 1872 | — | — | — | — |
| 4 | Sandoz Developer of generic and biosimilar medicines | — | 142 mo ago | Public | Marie-Noëlle Désilets Executive Assistant to Chief Manufacturing & Supply Officer / Deputy Assistant to CEO | 1886 | Apple iCloud MailMicrosoft 365Node.js+11 | 48 signals ▼28% Leadership · Contracts · M&A | 2,081 patents Patents concentrated in chemistry & materials | — |
| 5 | Nycomed Manufacturer of branded medicines and OTC drugs | — | 401 mo ago | Acquired | — | 1874 | — | — | 12 patents Inhalable ciclesonide formulations and pyrazolone PDE4 inhibitors for respiratory, inflammatory, and metabolic therapies | — |
| 6 | 99 Technologies Manufacturer of pharmaceutical products | — | — | Funding Raised | — | 1999 | — | — | — | — |
| 7 | Acino Manufacturer of generic drugs | — | — | Acquired | Steffen Saltofte CEO | 1836 | WordPressApple iCloud MailMicrosoft 365+9 | — | — | — |
| 8 | Applied Pharma Research Manufacturer of prescription and over-the-counter pharmaceutical drugs | — | — | Acquired | Alberto Reiner Founder | 1990 | WordPressMySQLPHP+13 | — | — | — |
Top 4 Traditional Pharmaceuticals companies in Switzerland
#1
Public · Bern, Canton of Bern · founded 1927 · 2839 employees$156Mraised▾
Manufacturer of pharma and OTC products
#2
Late Stage · Lugano, Ticino · founded 1976 · 103 employees—raised▾
Developer of pharmaceutical products focused on cancer and chronic diseases. They operate an integrated licensing business model. The technical organization covers development, regulatory affairs, manufacturing, and supply chain. They focus on building brands globally through an extensive commercial and supply network. The business prioritizes the well-being of patients and society.
#3
Acquired · Opfikon, Zurich · founded 1872 · 2200 employees—raised▾
Provider of plasma-derived and recombinant therapies, and vaccines. This company develops and markets treatments for rare and serious diseases, including immunodeficiency and autoimmune diseases, hereditary bleeding disorders, and iron deficiency. A significant portion of its business focuses on influenza vaccines. The company also has a presence in nephrology, offering therapies for kidney disease. Research and development efforts concentrate on plasma protein technology, recombinant technology, cell and gene therapy, and vaccine technology.
#4
Public · Basel, Basel Stadt · founded 1886 · 1205 employees—raised▾
Developer of generic and biosimilar medicines. It is a global leader in generic and biosimilar pharmaceuticals, committed to driving access to medicine by developing affordable, high-quality treatments. With a portfolio of generic and biosimilar products, Sandoz provides innovative solutions to patients worldwide. The company's mission is to pioneer access to medicines for patients globally, focusing on making healthcare more affordable and accessible.
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Traditional Pharmaceuticals coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Drug Discovery is moving in Switzerland
A read on the academic research around Drug Discovery — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 947 Switzerland-affiliated papers.
- ETH Zurich175
- Novartis100
- Roche80
- École Polytechnique Fédérale de Lausanne79
- University of Basel76
- Computational biology15→84
- Chemical space11→51
- Small molecule4→30
- Pharmacology4→28
- High-throughput screening2→22
- Computational biology15→40
- Chemical space1→24
- Drug development1→20
- Virtual screening5→21
- In silico4→18
- Computational biology8→29
- Data science2→9
- Drug development4→10
- Bioinformatics2→7
- Chemical space3→8
Where drug discovery is researched across Switzerland
Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.
Common questions
Riya reads income statements for fun. She covers the real money in a sector — revenue, growth, who actually earns — and never met a vague claim she didn't want a number for.